Wei-Ting Chao Selected Research

Plectin

1/2018	Plectin deficiency in liver cancer cells promotes cell migration and sensitivity to sorafenib treatment.
10/2016	Cell Pleomorphism and Cytoskeleton Disorganization in Human Liver Cancer.
1/2015	Transient knockdown-mediated deficiency in plectin alters hepatocellular motility in association with activated FAK and Rac1-GTPase.
4/2011	Cytokeratin 18-mediated disorganization of intermediate filaments is induced by degradation of plectin in human liver cells.
3/2011	Plectin deficiency on cytoskeletal disorganization and transformation of human liver cells in vitro.
1/2011	Synemin down-regulation in human hepatocellular carcinoma does not destabilize cytoskeletons in vivo.
9/2008	Degradation of plectin with modulation of cytokeratin 18 in human liver cells during staurosporine-induced apoptosis.
4/2008	The influence of plectin deficiency on stability of cytokeratin18 in hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei-Ting Chao Research Topics

Disease

16	Neoplasms (Cancer) 01/2020 - 01/2011
12	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 04/2008
3	Breast Neoplasms (Breast Cancer) 04/2020 - 01/2015
3	Fibrosarcoma 03/2015 - 10/2013
3	Carcinogenesis 01/2015 - 04/2008
2	Stress Urinary Incontinence 07/2022 - 01/2022
2	Colonic Neoplasms (Colon Cancer) 04/2020 - 12/2016
2	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 01/2015
2	Infections 01/2018 - 10/2013
2	Colorectal Neoplasms (Colorectal Cancer) 12/2016 - 08/2014
1	Ascites 06/2021
1	Endometriosis 06/2021
1	Hematoma 09/2020
1	Hydronephrosis 03/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Pleural Effusion (Pleural Effusions) 12/2019
1	Pulmonary Embolism 12/2019
1	Venous Thromboembolism 12/2019
1	Ovarian Epithelial Carcinoma 01/2019
1	Perivascular Epithelioid Cell Neoplasms 01/2019
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2018
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 06/2018
1	Clear Cell Adenocarcinoma 06/2018
1	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 06/2018
1	Neurofibroma 02/2018
1	Cholangiocarcinoma 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Liver Neoplasms (Liver Cancer) 01/2018
1	Lymphatic Metastasis 12/2016
1	Osteosarcoma (Osteogenic Sarcoma) 06/2016

Drug/Important Bio-Agent (IBA)

8	PlectinIBA 01/2018 - 04/2008
4	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 01/2018
4	Cadherins (E-Cadherin)IBA 01/2019 - 08/2014
4	Pharmaceutical PreparationsIBA 01/2018 - 10/2013
3	Ado-Trastuzumab EmtansineIBA 04/2020 - 01/2015
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 08/2014
2	Immunoconjugates (Immunoconjugate)IBA 04/2020 - 01/2018
2	Metformin (Glucophage)FDA LinkGeneric 04/2020 - 01/2018
2	Trastuzumab (Herceptin)FDA Link 04/2020 - 01/2015
2	human ERBB2 proteinIBA 04/2020 - 01/2015
2	mesoglycanIBA 12/2019 - 02/2018
2	Caveolin 1IBA 01/2018 - 01/2015
2	Focal Adhesion Protein-Tyrosine KinasesIBA 06/2016 - 01/2015
2	Keratin-18 (Keratin 18)IBA 01/2015 - 04/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Dasatinib (BMS 354825)FDA Link 01/2021
1	CreatinineIBA 03/2020
1	ruxolitinibIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	dubermatinibIBA 01/2020
1	Janus Kinase InhibitorsIBA 01/2020
1	MTOR InhibitorsIBA 01/2019
1	DesminIBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2018
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 12/2018
1	EscinIBA 12/2018
1	Cytochromes c (Cytochrome c)IBA 12/2018
1	Death Domain ReceptorsIBA 12/2018
1	Tumor Biomarkers (Tumor Markers)IBA 06/2018
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 06/2018
1	GlypicansIBA 06/2018
1	Keratin-7 (Cytokeratin 7)IBA 06/2018
1	NFI Transcription FactorsIBA 06/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	AndrogensIBA 01/2018
1	Keratins (Keratin)IBA 01/2018
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 06/2016
1	Glucose (Dextrose)FDA LinkGeneric 06/2016
1	Deoxyglucose (2 Deoxy D glucose)IBA 06/2016
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 06/2016
1	Cisplatin (Platino)FDA LinkGeneric 06/2016
1	AgarIBA 06/2016
1	Histone Deacetylases (Histone Deacetylase)IBA 03/2015
1	Histones (Histone)IBA 03/2015
1	Histone Deacetylase 1IBA 03/2015
1	Adenosine Triphosphate (ATP)IBA 01/2015
1	DNA (Deoxyribonucleic Acid)IBA 01/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2015
1	Cardiolipins (Cardiolipin)IBA 01/2014
1	Peptides (Polypeptides)IBA 10/2013
1	Antimicrobial PeptidesIBA 10/2013
1	Anti-Infective Agents (Microbicides)IBA 10/2013
1	GoldIBA 10/2013
1	desmuslin (synemin)IBA 01/2011

Therapy/Procedure

4	Therapeutics 06/2021 - 01/2018
2	Suburethral Slings (Tension-Free Vaginal Tape) 07/2022 - 01/2022
2	Drug Therapy (Chemotherapy) 01/2019 - 01/2019
1	Debridement 09/2020
1	Compression Stockings 12/2019
1	Gynecologic Surgical Procedures (Gynecologic Surgery) 12/2019
1	Cytoreduction Surgical Procedures 01/2019
1	Subcutaneous Injections 01/2019